Eisai (United States)
Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Eisai (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
52%
Total
Publications
1.9K
Total Open
Publications
1K
Total
Citations
60K
Open Access
Percentage
52%
Total
Publications
1.9K
Total Open
Publications
1K
Total
Citations
60K
Breakdown
Publisher Open
25%
Both
21%
Other Platform Open
6%
Closed
48%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 23%
206
Hybrid 45%
399
No Guarantees 32%
278
Other Platform Open
Domain 87%
459
Institution 22%
117
Public 8%
43
Other Internet 8%
42
Preprint 2%
11
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 459 |
Europe PMC | Domain | 263 |
DOI | Other Internet | 51 |
Figshare | Public | 48 |
University College London - UCL Discovery | Institution | 31 |
Semantic Scholar | Public | 26 |
The University of Glasgow - Enlighten: Publications | Institution | 11 |
KU Leuven - Lirias | Institution | 9 |
Erasmus University Rotterdam - EUR Research Repository | Institution | 9 |
bioRxiv | Preprint | 8 |